Franklin Resources Inc Repare Therapeutics Inc. Transaction History

Franklin Resources Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$11.38 - $21.88 $1.52 Million - $2.93 Million	-133,773 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$19.66 - $28.11 $3.24 Million - $4.63 Million	-164,836 Reduced 55.2%	133,773 $2.82 Million
Q3 2021 Nov 12, 2021	BUY	$25.71 - $35.24 $5.4 Million - $7.4 Million	210,074 Added 237.28%	298,609 $7.84 Million
Q1 2021 May 13, 2021	SELL	$25.89 - $44.46 $10.5 Million - $18 Million	-404,837 Reduced 82.06%	88,535 $2.72 Million
Q4 2020 Feb 10, 2021	SELL	$23.42 - $39.5 $233,567 - $393,933	-9,973 Reduced 1.98%	493,372 $16.9 Million
Q3 2020 Nov 12, 2020	BUY	$21.55 - $33.92 $23,791 - $37,447	1,104 Added 0.22%	503,345 $15.5 Million
Q2 2020 Aug 13, 2020	BUY	$30.8 - $32.99 $15.5 Million - $16.6 Million	502,241 New	502,241 $11.3 Million

35.4M

50K

300

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $55.4M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.